Targeting PHGDH can re-sensitize resistant tumors to MAPK inhibition via the reduction of glutathione and the increment of oxidative stress.244,245 Therefore, PHGDH inhibition is a lethal partner with MAPK inhibitor for melanoma therapy. This evidence concerns the gene PHGDH and melanoma.